Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke

European Journal of Neurology

Volumn 17, Issue 1, 2010, Pages 111-117

  Bigalke, B ^a   Stellos, K ^a   Geisler, T ^a   Kremmer, E ^b   Seizer, P ^a   May, A E ^a   Lindemann, S ^a   Melms, A ^a   Luft, A ^c   Gawaz, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Glycoprotein VI; Platelets; Stroke; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL SURFACE MARKER; CLOPIDOGREL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; GLUCOSE; GLYCOPROTEIN IB; GLYCOPROTEIN VI; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PADGEM PROTEIN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STRUCTURED INTERVIEW; THROMBOCYTE ACTIVATION; TRANSIENT ISCHEMIC ATTACK;

AGED; BIOLOGICAL MARKERS; FEMALE; FLOW CYTOMETRY; HUMANS; INTRACRANIAL THROMBOSIS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET ADHESIVENESS; PLATELET MEMBRANE GLYCOPROTEINS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE; UP-REGULATION;

EID: 73449086712     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02754.x     Document Type: Article

References (32)

1. van der Worp HB, van Gijn J. Clinical practice. Acute ischemic stroke. N Engl J Med 2007 357 : 572 579.
2. Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993 24 : 35 41.
3. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006 113 : e409 e449.
4. Jauch EC, Lindsell C, Broderick J, et al. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006 37 : 2508 2513.
5. del Zoppo GJ, Milner R, Mabuchi T, et al. Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007 38 : 646 651.
6. Montaner J, Fernandez-Cadenas I, Molina CA, et al. Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke 2006 37 : 1205 1210.
7. Orion D, Schwammenthal Y, Reshef T, et al. Interleukin-6 and soluble intercellular adhesion molecule-1 in acute brain ischaemia. European Journal of Neurology 2008 15 : 323 328.
8. Kalinowska A, Losy J. PECAM-1, a key player in neuroinflammation. European Journal of Neurology 2006 13 : 1284 1290.
9. Montaner J. Stroke biomarkers: Can they help us to guide stroke thrombolysis? Drug News Perspective 2006 19 : 523 532.
10. Htun P, Fateh-Moghadam S, Tomandl B, et al. Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke 2006 37 : 2283 2287.
11. Fateh-Moghadam S, Htun P, Tomandl B, et al. Hyperresponsiveness of platelets in ischemic stroke. Thromb Haemost 2007 97 : 974 978.
12. Ruggeri ZM. Platelets in atherothrombosis. Nature Medicine 2002 8 : 1227 1234.
13. Furihata K, Clemetson KJ, Deguchi H, Kunicki TJ. Variation in human platelet glycoprotein VI content modulates glycoprotein VI-specific prothrombinase activity. Arteriosclerosis Thrombosis 2001 21 : 1857 1863.
14. Samaha FF, Hibbard C, Sacks J, et al. Density of platelet collagen receptors glycoprotein VI and alpha2beta1 and prior myocardial infarction in human subjects, a pilot study. Medical Science Monitor 2005 11 : CR224 CR229.
15. Bigalke B, Lindemann S, Ehlers R, et al. Expression of platelet collagen receptor VI is associated with acute coronary syndrome. Eur Heart J 2006 27 : 2165 2169.
16. Bigalke B, Geisler T, Stellos K, et al. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Am Heart J 2008 156 : 193 200.
17. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004 351 : 2170 2178.
18. Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurology 2006 5 : 603 612.
19. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007 357 : 2482 2494.
20. Patrono C, García Rodríguez LA, Landolfi R, et al. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005 353 : 2373 2383.
21. Marquardt L, Ruf A, Mansmann U, et al. Course of platelet activation markers after ischemic stroke. Stroke 2002 33 : 2570 2574.
22. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006 354 : 1706 1717.
23. Elkind MS. Anticoagulation for secondary stroke prevention: another nail in the coffin? Lancet Neurology 2007 6 : 97 99.
24. Geisler T, Kapp M, Göhring-Frischholz K, et al. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease. Heart 2008 94 : 743 747.
25. Amarenco P, Bogousslavsky J, Callahan A III., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006 355 : 549 559.
26. Martínez-Sánchez P, Rivera-Ordóñez C, Fuentes B, Ortega-Casarrubios MA, Idrovo L, Díez-Tejedor E. The beneficial effect of statins treatment by stroke subtype. European Journal of Neurology 2009 16 : 127 133.
27. Bigalke B, Langer H, Geisler T, Lindemann S, Gawaz M. Platelet glycoprotein VI: a novel marker for acute coronary syndrome. Seminar in Thrombosis and Hemostasis 2007 33 : 179 184.
28. Grüner S, Prostredna M, Aktas B, et al. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy. Circulation 2004 110 : 2946 2951.
29. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 2007 115 : 2323 2330.
30. Laske C, Leyhe T, Stransky E, et al. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease. J Psychiatr Res 2008 42 : 746 751.
31. Bigalke B, Stellos K, Weig HJ, et al. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). Basic Res Cardiol 2009 104 : 352 357.
32. Bigalke B, Stellos K, Stakos D, et al. Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome. Thromb Haemost 2009 101 : 911 915.